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DEBATE as part of teaching and learning in Radiotherapy

Final year PGDip Therapeutic Radiography students at London South Bank University participated in a debate as part of their formative assessments.  The topic was chosen by the unit lead to enable them to reflect on changes in practice resulting from the introduction of new technology in radiotherapy. The cohort of students were divided in two equal groups representing a voice for and against: The use of Arc Therapy and Tomotherapy
For preparation student had to research the topic and write a summary that included an introduction, a list of the main points, and a concluding paragraph. Guidance notes included role of the instructor, pointers on presentation and academic criteria.  Students were encouraged to consider how each of them would be involved in the presentation.   On the day of the debate each group were given 15 minutes to present their side of the argument. Those arguing pro presented first followed by against group.  During a 30min break after presentation the groups had to outline their rebuttal statements. Each group was then given 5 minutes to present their rebuttal statement. The debate concluded by allowing the whole group to vote individually.

Arguments were based on scientific publications and results from the debate raised some interesting points for consideration in radiotherapy practice.  The aim of this article is to share the findings from scientific knowledge gained from the debate.  A summary of the arguments are outlined below.

Introduction:






Arc Therapy was developed as a technique to tackle some of the limitations of fixed field treatments (3D conformal and fixed field IMRT) (Palma et al, 2010.) Studies have shown arc therapy, Rapid Arc in particular, to be able to produce equivalent or superior dose distributions than IMRT in a variety of cancers such as head and neck, prostate, anal and cervix. (Palma et al, 2008; Clivio et al, 2009; Cozzi et al, 2008; Vanetti et al, 2009; Verbakel et al, 2009.)  Arc therapy can produce better dose distributions whilst reducing treatment delivery time to 1.5-3 minutes compared to IMRT where treatments depend on complexity and vary from 10-45 minutes due to the sheer number of beamlets used. The use a single arc rotation to deliver arc therapy is therefore very advantageous as less treatment time could mean more patient throughput. In addition to reducing treatments times, a reduction of monitor units by around 50% can also be achieved.  Palma et al, 2008; Clivio et al, 2009; Cozzi et al, 2008; Vanetti et al, 2009; Verbakel et al, 2009.) A reduction in monitors units ultimately results in less scattered radiation and could theoretically reduce the chance of secondary malignancies. Linear accelerators are used for treatment delivery and therefore limited training is required for staff in terms on new equipment use. Furthermore, the patients’ pre-treatment pathway remains much the same, with use of CT and MRI and PET fusion when available as the main localization modalities.  Standard linacs can be upgraded to perform arc therapy and although it is deemed expensive (£600,000), it is still viewed as a cost-effective alternative in terms of superior treatment delivery.  The use of a linac allows for flexibility as patients not requiring arc treatment can still have electrons or other MV treatments (Palma et al 2010) thereby enhancing integration. 

Pro Tomotherapy
Literature supports the use of Tomotherapy over that of linac-based IMRT in terms of delivering dose correctly and ensuring OAR sparing, highly conformal dose distributions and improved dose homogeneity within the PTV.  (Javedan, K. et al (2009), Jhaveri, PM. et al (2009), Kron, T. et al (2004), Loo, H. et al (2011), McCutcheon, KW. et al (2008), Raber, J. et al (2004), Sheng, K. et al (2007), Sheng, K. et al (2006), Zhuang, AH. et al (2009).  It has also shown to be an acceptable alternative to brachytherapy. Hsieh et al (2010).  Imaging advantages includes less dose at depth compared with portal imaging; typical values are 1.3cGy. The total overall dose is less than 1Gy during the whole course of treatment (Burnet et al, 2010, Geets et al, 2007).  When compared with MV cone beam CT tomotherapy fan beam CT contributes less additional dose.  Patient acceptance is high as it resembles a conventional CT scanner and therefore less intimidating (Burnet et al, 2010). Other patient advantages include quick planning and treatment delivery for emergency patients (McIntosh, A. et al, 2010). and simultaneous multi-target radiotherapy, for example metastases. Chargari, C. et al (2008), Kim, JY. et al (2009).

Pro Concluding summary
	Strong evidence base in support of these treatments
	Advantages outweigh current standard practice
	Widely accepted across the world
	National Radiotherapy Awareness Initiative 2011
	Increased public awareness will drive change in radiotherapy services currently provided
	Foundation Trusts have the financial autonomy to make these capital investments
	Progression is necessary. Unless we are given the opportunity to refine and evaluate these treatments, how are we going to improve them to drive forward the innovations and improvements for future generations?

Against – tomotherapy and arc therapy
Issues
Training is all encompassing and interprofessional, with not only radiographers, but physicists, planners and oncologists all requiring significant training to become familiar and competent with all components of operations, planning and treatment.  As well as becoming competent in the operation and treating with the new technology, radiographers must be trained in image verification using CT images over bony anatomy DRRs.  Dedicated training packages must be acquired and taught which could ultimately lead to understaffed departments and the removal of manpower (Burnet et al, 2010).  
Too much reliance is placed on the software generating an optimum plan and using the correct algorithms, it is a purely mathematical process with a lack of human intuition and ultimately a fundamental loss of skills.  The inverse planning system will focus primarily on dose constraints to OARs/normal tissues that have been identified and this could compromise the optimal dose distribution to the PTV (Burnet et al, 2010; Yartsev et al, 2006).  Accurate delineation of the target volume is even more critical with arc and tomotherapy as margins are tighter with the increased conformality it aims to give over that of a conventional plan.  There is the potential for a greater risk of geographical miss, especially if there is intrafractional movement when the margins are tighter (Nestle et al, 2008).  The patient’s performance status is an important issue for arc and tomotherapy patients as they must remain still to avoid large intrafractional movements during the relatively long treatment period. Due to the increased conformality of these technologies, intrafractional movement is more of an issue because margins are narrower. Other factors include patient breathlessness and claustrophobia (Burnet et al, 2010). 
There is also the issue of integral dose.  Tomotherapy has been shown to deliver a higher integral dose to patients.  On average 20% higher integral dose was received in this study with risks not yet established (Oliver, 2009).  An implication of increased integral dose may be the potential for secondary malignancies, but research is conclusive that radiation is carcinogenic. Hall and Wuu (2003) state that due to increased exposure of normal tissue to lower doses of radiation there may be “double the incidence of secondary malignancies compared with conventional radiotherapy from about 1 % to 1.75% for patients surviving ten years” p83. This is of particular relevance for paediatric patients.
The inverse planning system has a further downside in that planning time, on average, for IMRT is 7.5mins, 48mins for rapid arc, and 59mins for tomotherapy (Oliver et al, 2009).  The increased conformality of plans from these technologies also gives greater treatment times so raising a compromise over quality of plan vs treatment time.  Studies show that keeping a lower treatment time will predominantly be considered as the most important factor in order to ensure a cost-effective patient throughput each working day (Burnet et al, 2010; Oliver et al, 2009).  A back-up plan strategy is required to cover machine servicing and breakdown.  The workload required to generate back-up plans takes time away from more patients being able to be treated with the new technologies, and also adds significant work pressure to the planners who are planning conventional treatment plans (Burnet et al, 2010). More importantly, for the patient there is a possible psychological impact from being transferred from a superior treatment modality to what the patient may perceive as a substandard treatment. 
Other considerations are the high cost – not only of the machine, but the whole package – installation, training, maintenance, extra use of resources.  Sources show that tomotherapy costs are double that of IMRT, with annual maintenance costs up to four times as great (National Horizon Scanning Centre, 2006).  Finally for tomotherapy there are no existing official routine QA procedures (Yartsev et al, 2006). Some conventional linac procedures apply, however many don’t.  Important additional checks to helical delivery and integrated imaging system must be carried out (Burnet et al, 2010). 

Against Concluding Summary




Students in the ‘Against’ group presented their peers with questions regarding the implementation and use of arc and tomotherapy.  These questions were address in the rebuttal discussions after which students were given the opportunity to vote.  The wining vote was awarded to the ‘Pro’ group.

Questions for consideration:
1.	Is introducing this technology too much of a drain on existing resources and how will this impact on the quality of patient care?
2.	If only a limited number of patients can be treated in a day (approximately half the number that can be treated conventionally), how are patients selected?
3.	 How can you ensure consistency and accuracy in your daily routine QAs if there is no gold standard national protocol?
4.	Can you justify the high cost of regular maintenance and the implications of unforeseen downtime on the patients’ treatment?
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